Medicine & Life Sciences

1. Anaplastic Large-Cell Lymphoma 100%
2. Peripheral T-Cell Lymphoma 82%
3. Lymphoma, Large B-Cell, Diffuse 68%
4. Lymphoma 65%
5. T-Cell Lymphoma 65%
6. Follicular Lymphoma 60%
7. Non-Hodgkin's Lymphoma 38%
8. B-Cell Lymphoma 37%
9. Neoplasms 36%
10. Endostatins 31%
11. T-Lymphocytes 31%
12. Lymphoproliferative Disorders 26%
13. B-Lymphocytes 26%
14. Anaplastic Lymphoma Kinase 25%
15. Progression-Free Survival 22%
16. Hodgkin Disease 22%
17. Survival 20%
18. Fluorescence In Situ Hybridization 19%
19. Breast Implants 19%
20. Mutation 18%
21. Immunohistochemistry 17%
22. Gene Expression Profiling 15%
23. Mantle-Cell Lymphoma 14%
24. Dendritic Cells 14%
25. Rituximab 14%
26. Genes 14%
27. Lymphomatoid Papulosis 14%
28. Skin 13%
29. Confidence Intervals 12%
30. interferon regulatory factor-4 12%
31. Extranodal NK-T-Cell Lymphoma 12%
32. Human Herpesvirus 4 12%
33. Therapeutics 11%
34. Angiogenesis Inhibitors 10%
35. B-Cell Chronic Lymphocytic Leukemia 10%
36. Growth 10%
37. Proteins 10%
38. Tumor Microenvironment 9%
39. Natural Killer Cells 9%
40. Genome 9%
41. Germinal Center 9%
42. High-Throughput Nucleotide Sequencing 8%
43. Plasmablastic Lymphoma 8%
44. Molecular Epidemiology 8%
45. Drug Therapy 8%
46. Waldenstrom Macroglobulinemia 7%
47. Paraffin 7%
48. Odds Ratio 7%
49. T-Cell Antigen Receptor 7%
50. Hematologic Neoplasms 7%